Clinical and Translational Medicine (Jun 2020)
Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
- Anlin Li,
- Yongjian Chen,
- Wenda Zhang,
- Haitao Zhong,
- Qiyun Ou,
- Yang Gu,
- Junqing Xia,
- Dagui Lin,
- Tuping Fu,
- Ruixin Liu,
- Hai Hu,
- Yunfang Yu,
- Herui Yao
Affiliations
- Anlin Li
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Yongjian Chen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Wenda Zhang
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Haitao Zhong
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Qiyun Ou
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Yang Gu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Junqing Xia
- The First Clinical Medical College Southern Medical University Guangzhou China
- Dagui Lin
- Sun Yat‐sen University Cancer Center Guangzhou China
- Tuping Fu
- Sun Yat‐sen University Cancer Center Guangzhou China
- Ruixin Liu
- Guangdong Key Laboratory for Research and Development of Natural Drugs Guangdong Medical University Zhanjiang China
- Hai Hu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Yunfang Yu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- Herui Yao
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
- DOI
- https://doi.org/10.1002/ctm2.92
- Journal volume & issue
-
Vol. 10,
no. 2
pp. n/a – n/a
Abstract
No abstracts available.